Tokyo, August 26, 2020: Eisai Co., Ltd. announced today that a total of 10 presentations including the latest data on…
Tokyo, June 04, 2020: Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has launched its in-house discovered…
Tokyo September 21, 2019: Eisai Co., Ltd. has announced that latest data on lemborexant, an investigational sleep-wake regulation agent being…
New Delhi, May 02, 2019: Eisai Co., Ltd. announces that its U.S. subsidiary Eisai Inc. has bought out Purdue Pharma…
New Delhi, April 25, 2019: Eisai Co., Ltd. has announced that the latest data on its dual orexin receptor antagonist…
New Delhi, March 14, 2019: Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue…
New Delhi, March 08, 2019: Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for…
Tokyo, February 17, 2019: Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase…
At 43rd Annual Meeting of The Japan Society of Sleep Research At “Drug Discovery Research For Sleep Medicine” Symposium Tokyo,…